News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Diego Díaz García: Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials
Diego A. Díaz García/X
Jun 22, 2025, 11:09

Diego Díaz García: Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials

Diego Díaz García, Medical Oncologist, CEO and Founder of CánCare, posted on X:

“Are we overestimating success in ph3 oncology trials?
Only 6% of ph3 oncology RCTs show improvement in both OS and QoL.
Most “positive” trials rely on surrogate endpoints, often without adjusting QoL for baseline. We must refocus trials on what truly matters to patients.”

Title: Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials

Authors: Alexander D. Sherry, Avital M. Miller, Jnana Preeti Parlapalli, Gabrielle S. Kupferman, Esther J. Beck, Jordan McDonald, Ramez Kouzy, Joseph Abi Jaoude, Timothy A. Lin, Nina N. Sanford, Fumiko Chino, Bishal Gyawali, Christopher Booth, Pavlos Msaouel, Ethan B. Ludmir

Read The Full Article at JAMA Oncology.

Diego Díaz García: Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials

More posts featuring Diego Díaz García.

Alexander D. Sherry Avital M Miller Bishal Gyawali cancer Christopher Booth Diego Díaz García Esther J Beck Ethan B Ludmir Fumiko Chino Gabrielle S Kupferman Jnana Preeti Parlapalli Jordan McDonald Joseph Abi Jaoude Nina N. Sanford OncoDaily Oncology Pavlos Msaouel Ramez Kouzy Timothy A Lin
Special Coverage
Blog
Jul 12, 2025, 13:02
Walk The World 2025 - World Child Cancer
Blog
Jul 12, 2025, 12:46
"Metastatic Breast Cancer Impact Award" Winner - Conquer Cancer, the ASCO Foundation
Blog
Jul 12, 2025, 12:04
Teresa Amaral: The Last Day of the ICF Short Fellowship with Konstantinos Lallas at the Skin Cancer Clinical Trials Center
Blog
Jul 12, 2025, 12:01
Levon N Grigoryan: Very Proud to Have You as a Mentor in My Professional Career
Blog
Jul 12, 2025, 11:58
Debra Patt: The Power of Advocacy in Cancer Care
Blog
Jul 12, 2025, 11:54
Thomas Hartung: NIH Announces End to Funding for Animal-only Studies
Opinion
Jul 12, 2025, 11:48
Siobhan Freeney: Telling a Woman who has Dense Breasts that her Mammogram is 'Clear' is Incomplete Information
Science
Jul 12, 2025, 11:44
Myeloma Paper of the Day, July 12th, Suggested by Robert Orlowski
Career
Jul 12, 2025, 10:00
Liang Cheng: Seeking a Molecular Pathologist to Join Our Team in Providence, Rhode Island
Blog
Jul 12, 2025, 09:48
Tinatin Alaverdashvili: This Subject Has Fascinated Me from the Very Beginning
Blog
Jul 12, 2025, 09:37
Wafaa M Rashed: 9th cohort of Policy Advocacy in Genetics and Genomics Course
Blog
Jul 12, 2025, 09:17
Elizabeth Ugwoma Awo-Ejeh: Let’s Break the Silence